Jove
Visualize
Contact Us

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Pancreas01:19

Pancreas

The pancreas, an essential organ in the human body, is a pinkish-gray elongated structure located posterior to the stomach. It extends laterally from the duodenum towards the spleen and is firmly bound to the posterior wall of the abdominal cavity. The organ's surface has a lumpy, lobular texture that gives it a unique appearance.
The broad head of the pancreas lies within the loop formed by the duodenum, while its slender body reaches towards the spleen. The tail of the pancreas is short and...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declining research interest among oncology residents: insights into the academic career from a nationwide longitudinal study in France.

ESMO open·2026
Same author

Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.

British journal of haematology·2024
Same author

Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. Letter to the Editor regarding: "Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up" by Huguet et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

[Informed consent in radiotherapy care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Practice-changing clinical trials in radiation oncology for gastrointestinal malignancies in 2021-2023.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same journal

Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 6, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

[Pancreatic cancer].

F Huguet1, A Orthuon, E Touboul

  • 1Service d'oncologie radiothérapie, hôpital Tenon, Assistance-Publique-Hôpitaux de Paris, Université Paris VI, 4, rue de la Chine, 75020 Paris, France. florence.huguet@tnn.aphp.fr

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|December 7, 2010
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer radiotherapy is controversial, but chemoradiation (CRT) may improve survival for incompletely resected tumors. Further trials are needed to evaluate neoadjuvant CRT and refine treatment strategies for advanced pancreatic cancer.

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Related Experiment Videos

Last Updated: Jun 6, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Area of Science:

  • Oncology
  • Radiotherapy
  • Surgical Oncology

Context:

  • Pancreatic adenocarcinoma presents a significant clinical challenge with limited surgical options for most patients at diagnosis.
  • Post-surgical survival for resected pancreatic cancer is often limited (12-20 months) with frequent relapses.
  • Current adjuvant treatment involves chemotherapy (FUFOL or gemcitabine), but radiotherapy's role remains debated.

Purpose:

  • To clarify the radio-anatomical features of pancreatic cancer.
  • To delineate the patterns of spread for pancreatic adenocarcinoma.
  • To explain the principles of 3D conformal radiotherapy in pancreatic cancer management, including a clinical case.

Summary:

  • Chemoradiation (CRT) shows potential in improving survival for patients with R1 resected pancreatic tumors, warranting prospective validation.
  • Neoadjuvant CRT is an emerging strategy for locally advanced pancreatic cancer, currently under investigation.
  • Treatment strategies for locally advanced pancreatic cancer are evolving, with initial chemotherapy followed by CRT for non-progressing patients being evaluated.
  • Modern radiotherapy techniques focus on reducing treated volumes for improved tolerance, aided by simulation CT for precise target delineation.

Impact:

  • This work aims to provide a comprehensive understanding of radiotherapy's role and technical considerations in pancreatic cancer.
  • Improved understanding can guide the development of more effective and tolerable treatment protocols for pancreatic cancer patients.
  • The findings may contribute to refining treatment strategies, potentially improving outcomes for patients with locally advanced or incompletely resected pancreatic tumors.